Apollo Endosurgery (APEN) Misses Q4 EPS by 8c

Apollo Endosurgery (NASDAQ: APEN) reported Q4 EPS of ($0.42), $0.08 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $16.64 million.

For earnings history and earnings-related data on Apollo Endosurgery (APEN) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance